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THE TUBERCLE BACILLUS AND FUNDAMENTAL
CHEMOTHERAPEUTIC AND ANTIBIOTIC ACTION*
H. J. CORPER AND MAURICE L. COHN
Tremendous strides have been made in recent years toward
chemotherapiles in a number of diseases. However, the "major
mummer among diseases," tuberculosis, has confused not only the
public by its vagaries but has baffled the average clinician as well as
the clinical investigator. The last of these usually feels that the
final criterion for a chemotherapy in tuberculosis is the successful
treatment of the disease in the human being, so that experimental
laboratory work is unnecessary or only cursory tests should be done
there. They feel the human being should be used immediately
without thought of possible harm, both physical and mental, to the
tuberculous patient. Above all, they ignore their inability to estab-
lish proper controls to any relative therapy among human beings
afflicted with even predominantly pulmonary disease. Of course,
the use of animals is far more economical and yields more extensive
information, especially when an expensive agent is involved, as is
evident from relative weight considerations alone.
The therapeutic failures of the past, outstanding among which
was tulberculin with its hasty human application and disaster, might
have been justified in those days of sparse knowledge of the disease,
but there can be no justification for the trials wi-th the Von Linden
copper treatment or the Moellgaard sanocrysin. Fortunately, the
extensive use of the sulfa drugs for human tuberculosis was checked
by exacting and intensive laboratory studies. With new prepara-
tions, which are both expensive and difficult to prepare, a wasteful
and extravagant use on human beings only curtails or prevents
elucidating laboratory and animal experimentation. A goodl illus-
tration of the extreme value of laboratory investigation of chemo-
'therapeutic agents is the recent work on diasone.7 These studies
pointed out'that "the retarding effect on tuberculosis in the guinea
pig does not appear to be due to any direct cidal or static action of
* From the Research Department, National Jewish Hospital at Denver,
Colorado. This investigation was aided by a gift from Morton May in memory
of Florence G. May.
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the diasone itself"; also, "the effect of diasone treatment on the
tulberculosis of guinea pigs appears to be directly related to the
cyanotic effect on the internal organs"; and, "it is doubtful whether
a therapeutic effect for diasone has been attained clinically in tuber-
culosis in man with the sulfonamide or sulfone drugs thus far...
In view of the greater sensitivity of the human being to anoxic and
anoxemic effects and the fact that such a mechanism appears to
explain the favorable results noted on tuberculosis in the guinea
pig, it would not seem warranted to continue human experimenta-
tion with these drugs at present. . ." That only negative results
from the use of such therapy in tuberculosis in human beings can
accrue is amply demonstrated by an exhaustive study made by Tice,
Sweany, and Davison.26 They state, "The results of the treat-
ment with both drugs were essentially negative so far as favorable
effects on the disease tuberculosis were concerned. A few cases
appeared to be injured by the treatment." They, add, how-
ever, ". . . nor should our findings discourage further attempts
to find a chemotherapeutic agent for a treatment of the disease."
To those few who have faith in the possibility of a specific
chemotherapy in tuberculosis, there is a close resemblance, except in
name, between the application of chemotherapy and of antibiotics.19
The character of the latter is less exact because the chemical is of
unknown composition, while the character of the former is usually
known and chosen from synthetic chemicals rather than from natu-
rally occurring materials. However, antibiotic research is not new
to the study of tuberculosis, since in 1932,5 just ten years after
Fleming described lysozyme, it was shown that this agent did not
possess an appreciable inhibitory or bactericidal effect on tubercle
bacilli in vitro. It was pointed out also that the action of lysozyme
did not appear to be a factor in accounting for any organic suscepti-
bility to tuberculosis in animals. To a great extent, the latter
phenomenon is still unexplained by any known factors in the animal
economy unless the phagocytes and oxygen tension oif the organs
play some part. This, however, does not fully explain the differ-
ence occurring in different animal species. The retarding effect
of contaminations on the growth of tubercle bacilli in culture was
such a routine occurrence in the laboratory that its mechanism was
relegated to some simple explanation, such as the pH, exhaustion
of the medium, spoilage, etc., until the antibiotics were heralded as
therapeutic agents for bacterial diseases.
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In 1929 the classic studies of Fleming on penicillin appeared
and its usefulness not only in culture for preventing contaminations
of gram-negative. forms but its relative lack of toxicity for animals
and for leukocytes was pointed out.'4 Until 1940, few reports on
penicillin had appeared. Then the Oxford group reported the use
of potent concentrates, and today penicillin occupies the topmost
position in the list of important antibiotics even though it p-roved of
no value in tu-berculosis, even in the test-tube. The list of antibiotic
substances produced by molds and fungi is a large one and is still
expanding.
Waksman has described a number of the more recent antibiotics,
among them actinomycin A and B, streptothricin (1941) from A.
lavendulae, and streptomycin (1944). It is interesting that he
notes on page 106 of his 1945 text27 that A. griseus does not form
a zone of inhibition around M. tubercihlosis. Since 1944 interest
has centered on streptomycin21 rather than on streptothricin,
primarily because it is less toxic and possesses greater activity against
various gram-negative bacteria and toward streptothricin-resistant
organisms. It is prepared from Actinomyces griseus, and its name
originated because it was produced by one of the actinomycetes
which sporulates and produces aerial mycelia and to which Waks-
man and Henrici gave the generic name "Streptomyces." In the
early work Waksman recovered 30 units per milligram of dry
product."6 Since then, Merck & Co. has prepared a product con-
taining 1,000 units per milligram, as tested against E. coli.
A preliminary report by Feldman and Hinshaw12 noted that
Waksman and his coworkers had shown by experiments in vitro
that streptomycin was capable of exerting marked bacteriostatic and
bactericidal effects against a human strain of M. tuberculosis.
Because of this in vitro effect and its low toxicity for animals, they
studied the effect on guinea-pigs, reaching the conclusion that strep-
tomycin exerted "a striking suppressive effect on tthe pathogenic
proclivities in guinea pigs of the human variety of Mycobacterium
tuberculosis." The same year Robinson, Smith, and Graessle'
pointed out that streptomycin possessed advantages iover strepto-
thricin, particularly as to toxicity and a greater action toward certain
gram-negative and gram-positive bacteria in vivo, al-though strepto-
thricin seemed to be more effective than is streptomycin acting in
vitro against pathogenic fungi. In a further report, Stebbins,
Graessle, and Robinson25 noted that streptomycin is rapidly albsorbed
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and excreted following parenteral administration, 60 to 80 per cent
being excreted in the urine within 24 hours by dogs and monkeys.
Peak blood levels were reached within 30 minutes after injection
and *then the level declined fairly rapidly within a few hours.
Given perorally, relatively small amounts are detected in the blood
because of lack of absorption from the gastro-intestinal tract.
Streptothricin and streptomycin fed to mice reduced the number of
coliform and non-lactose fermenting organisms in the feces, and this
was maintained as long as therapy was continued.' Smith and
McClosky24 noted that the daily intramuscular injection of 5,000
units of streptomycin over a period of 90 days in guinea-pigs
infected with a human strain of tubercle bacilli produced a chemo-
therapeutic effect superior to that obtained with 0.5 gm. of promin
per kg. given orally for the same length of time. On cultures of
rabbit's spleen, streptomycin displayed a uniformly low toxicity."5
In adult men, Anderson and Jewell' studied the distribution of
50,000 to 150,000 units per cc. by intravenous, intramuscular, and
subcutaneous administration. Streptomycin is not albsorbed after
oral administration in amounts sufficient to be detectable in the
serum. The serum concentration curves do not differ significantly
except during a few minutes after intramuscular or intravenous
injection: from 46 to 87 per cent is recovered in the urine within
24 hours. In patients with meningitis, streptomycin diffuses to a
slight extent from the blood into the cerebrospinal fluid. Intra-
thecally, doses up to 20,000 units produce no signs of meningeal
irritation. . No toxic reactions followed the single injection of
600,000 units or after continued administration for two to three
weeks in doses totalling 2.7 to 18.1 million units. The intravenous
or subcutaneous injection of concentrated solutions caused too
much discomfort to warrant using these routes. Intravenous infusion
can be used without unpleasant symptoms. Intramuscular injec-
tions are fairly well tolerated for periods up to one or two weeks,
but beyond this severe discomfort results. Reporting on the toxicity
of streptomycin for man, Hettig and Adcock note"7 that limited
tests of renal and hepatic function together with blood studies before
and after administration of streptomycin revealed no evidence of
serious toxicity. Reactions such as fever, arth'ralgias, and skin
rashes, as well as histamine-like effects, are believed to 'be due to
impurities.
In an exhaustive study of its distribution, Kornegay, Forgacs,
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and Henley'8 found that 5,000 and 10,000 units of streptomycin
per kg. in mice produced a maximum blood level of 8 units per cc.,
or higher, then the concentration dropped rapidly and the drug had
disappeared in two hours. Of the organs assayed, the liver and
spleen were negative at all times and the kidney concentration was
so low that it indicated the drug was present merely in a state pre-
paratory to elimination. In thie guinea-pig, blood levels vary with
the route of administration. Variations in blood levels were
observed with changes in dosage and it was found in the blood as
late as 6 hours after injection. Rabbits retain the drug sufficiently,
like guinea-pigs, to permit administration at 3 to 4-hour intervals.
After 10,000 units intramuscularly, blood levels range from 10 units
at 30 minutes to 1.5 units at 6 hours. In monkeys, blood levels
ranged from 25 units at 15 minutes to less than 0.5 unit at 5 hours.
In man, a dose of 30,000 units given every 3 hours intramuscularly
will provide a blood level of from 1 to 25 units pier cc., and the
blood level can be increased by increasing the dose. In 1946,
Baggenstoss, Feldman, and Hinshaw2 maintained that "There is
convincing evidence that streptomycin (daily 6,000 units in divided
doses) exerts a profound regressive action on the morphologic
aspects of well established tuberculosis in guinea pigs." From the
study of five fatal cases in human beings treated with streptomycin,
they "suggest that following a period of treatment-lasting several
weeks or more, tuberculous lesions in thie spleen, liver, and especially
the lungs are more discrete and less cellular. . . The meningeal
lesiQns in some cases were regressing or were no longer demon-
strable, although in some instances an apparently uninhibited focal
tuberculous encephalitis was present." The possibility of strepto-
mycin fastness or an increased resistance of as much as 1,000-fold
was voiced by Youmans, Williston, Feldman, and Hinshaaw8 in
1946.
Preparation of streptomwycin
The studies presented here were initiated early in 1945 when we
were unable to obtain streptomycin from outside sources. Dr.
Waksman, however, sent us cultures of A. lavendulae and A. griseus,
with brnef directions for making streptomycin and streptothriin.
Although we found A. griseus would retard the growth of a human
strain of tu(bercle bacilli on glycerol agar plates relatively heavily
planted, the mold growth did not destroy the bacilli even up to 6
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months' contact. Our attempts to obtain streptomycin by the
method outlined by Dr. Waksman were not very successful because
of the destruction of the streptomycin by the acid aloohol used in
his procedure. Niot until we used the modified method described
by Carter, Clark, Dickman, Loo, Skell, and Strong3 were we able
to produce adequa.te and satisfactory amounts for even small-scale
experimentation. All appeals to pharmaceutical houses and to the
National Research Council failed until the early part of 1946 when
we were able todbtain 0.5 gm. of Merck's streptomycin through Dr.
Chester Keefer with titre given against E. coli so that we might
run adequate comparison standards with our own preparations.
The early preparations using Waksman's broth (tryptone) medium29
contained a high percentage of broth materials adsorbed on the active
carbon along with the streptomycin, so that the 'titre per mg. was
only about 100 units in these preparations, equaling the reported
early titres of Waksman and Merck. By'growing the A. griseus
on a nonprotein synthetic medium, although the weight yield was
less, the unit yield was about the same and the material was more
nearly pure, with a titre comparable to that sent us by Dr. Keefer
(about 1,000 units per mg.). This is the material that was used
for most of our recent experiments in this report. A purer material
also appears desirable since brain-heart infusion has been found to
interfere with the action of streptomycin by Wallace et al.30
Assay
The assay of antibiotics is open to much criticism and is far from
being an exact procedure. Many methods have been described for
streptomycin,1' 11, 13, 22, 28 and a variety of 'microorganisms have
been used for standard test induding E. coli, Staph. aureus, B. cir-
culans, B. subtilis spores, etc., so that even the standard material
must be viewed in the light of the test organism. For this reason,
all of our tests were made with at least two microorganisms-the
E. coli used by Merck for assay and upon which their units depend,
and an acid-fast saprophyte termed "Day" (carriled for several
decades in our group of stock organisms). Although "Day" grows
more rapidly, it is less susceptible to retardation in a poor nutrient
than is M. tuberculosis, but it is also slightly more susceptible to
cidal action than is the latter. However, with careful evaluation of
these fac-tors, this acid-fast saprophyte proved valuable for speedy
evaluation of at least short-period retarding actions of streptomycin
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and, within limitations, as a cl.ear-cut gauge of its presence and
activity. In order to compare a titration between E. coli and this
acid-fast saprophyte, the test recorded in table 1 was performed,
with broth as nutrient.
The findings recorded in table 1 point out the difficulty in defin-
ing a unit by the E. coli test when quantitative graded planting is
carried out; while with the "Day" culture the definition of the unit
is far more distinct in the broth medium. Another reason for pre-
ferring the acid-fast saprophyte "Day" was its closer resemblance
to the tulbercle bacillus primarily und.er consideratiion in this study.
The effect of streptomycin on the growth of tubercle bacilli in
a good or poor nutrient medium
The growth of tubercle bacilli on egg-yolk glycerol mediutm
occurs with plaints as low as 108 mg. per cc.; while on a poor
nutrient, such as nutrient broth glycerol agar mediums, plants of
1 mg. or more are required to produce successful growth. In the
egg-yolk glycerol medium, 100 units of streptomycin per cc. only
slightly retard the growth of plants of 0.01 mg. per cc. of tubercle
bacilli; while in nutrient glycerol agar medium, 1 unit per cc. of
streptomycin produces the same effect as above in retarding the
growth of plants of 1 mg. per cc. of tubercle bacilli. Thus it is
readilyseen that streptomycin possesses at least 100 times the retard-
ing effect on tubercle bacilli in a poor nutrient as compared with its
effect in a good nutrient medium.
On the other hand, "Day," an acid-fast saprophyte, grows well
on nutrient glycerol agar, and the growth of plants of 1 mg. per
cc. is not retarded by 10 units of streptomycin per cc. of medium.
Growth is completely retarded by 100 units of streptomycin per cc.
of medium; while in egg-yolk glycerol medium, 100 units strepto-
mycin per cc. of medium do not retard the growth of 1 mg. plants
of the acid-fast saprophyte "Day." Complete retardation occurs
however when 1,000 units of streptomycin are contained in 1 cc. of
medium. Streptomycin is 10 times more efficient as a retardant to
acid-fast saprophyte "Day" in nutrient glycerol agar as compared
with its retarding action in egg-yolk glycerol medium.
Long's synthetic liquid medium and Wong Weinzirl synthetic
liquid miedium are classified as poor nutrients, since plants of lumps
ofbacilli or ofsuspensions containing over 1 mg. per cc. are required
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to obtain successful growth. It must be recognized that in such
poor nutrient mediums the presence of any detrimental or retarding
influence is greatly accentuated and such retardations can hardly
occur in vivo where nutrient conditions and interference reactions
are usually more accentuated.4 6 8
The tuberculo-static and the tuberculo-cidal action of streptomycin
In order to note the retarding effect of streptomycin on the
growth of tubercle bacilli in a good nutrient, concentrations rang-
ing from none to 10,000 units per cc. oif medium were added to the
egg-yolk glycerol medium which was then planted wi,th graded
amounts of tubercle bacilli. The results of this experiment are
recorded briefly in table 2.
TABLE 2
GROWTH RETARDING ACTION OF STREPTOMYCIN FOR TUBERCLE BACILLI IN A GOOD
NUTRIENT MEDIUM, EGG-YOLK GLYCEROL
Units of streptomycin Amount of tubercie bacilliplmted (mg./cc.)
incorporated in ftuece___ plnd(g/.
medium 10-2 10-4 1 -6
0 2* 2 I 3
10 1 2 2 3
100 4 0 1 0
1,000 0 0 0
10,000 0 0 0
* The numerals indicate the number of weeks after planting when growth
appeared.
NOTE: 1,000 units of streptomycin completely inhibit "Day," an acid-fast
saprophyte, in the egg-yolk glycerol medium. The heat used to inspissate this
medium-15 minutes at 80-85° C.-has no effect on the streptomycin content
as shown by assays with E. coli in nutrient broth in which heated streptomycin,
15 minutes in boiling water-bath, gave the same inhibition as when unheated.
One unit of streptomycin will inhibit the growth of "Day" in nutrient broth,
indicating that the efficiency of the streptomycin is reduced (approximately) to
less than 1/100 of its efficiency when in a good nutrient as compared with a poor
nutrient medium, such as nutrient broth.
The data recorded in table 2 indicate that 100 units of strepto-
mycin retard small plantings of 104 and 1O6 mg. of human tubercle
bacilli, but this amount will only partially retard the growth of
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0.01 mg. plantings, 1,000 units being required for complete
retardation.
The retarding effect of streptomycinr in blood nutrient is
recorded in table 3, which indicates that an intravenous injection of
about 20,000 units of streptomycin into a guinea-pig 15 minutes
prior to withdrawing the blood for test is required t,o give a high
enough concentration to retard complet.ely the growth of human
tuberde 'bacilli; 2,000 units proved inadequate for this purpose.
TABLE 3
THE GROWTH RETARDING ACTION FOR TUBERCLE BACILLI OF STREPTOMYCIN IN
BLOOD* TAKEN FROM GUINEA-PIGS GIVEN STREPTOMYCIN INTRAVENOUSLY
Amount of tubercle bacilli (mg./cc.)
Units of streptomycin planted on the blood mediunt
given intravenously 10-2 10-4 10-6
0
Control 2§ 3 4
200,000
500-gram guinea-pig 0 0 0
20,000 l l
560-gram guinea-pig 1 0 | 0 0
2,000
544-gram guinea-pig 2 4 | 4
200
480-gram guinea-pig 2 3 4
* The blood was secured by cardiac puncture 10 to 15 minutes after the
intravenous injection (ear vein) of streptomycin.
t The blood medium was prepared by adding 25%o of water and 3%o of glycerol
before inspissating at 80 to 850 C. for 15 minutes. "Day," an acid-fast saprophyte
reacting like tubercle bacilli to antibiotics in vitro, showed the same retardation by
streptomycin as did the tubercle bacilli when planted on this medium.
§ The number indicates the weeks after planting when growth first appeared.
In order to study the tuberculocidal action of streptomycin,
varying concentrations were added to fine suspensions of tuberde
bacilli in saline and in the blood (citrated). The mixtures were
kept at 370 C. up to one week, after which.the streptomycin was
removed by washing and separation by centrifugation and the bacilli
were planted on a good nutrient medium (glycerol egg-yolk) with
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the results recorded in table 4 for the saline suspension and in table
5 for the blood suspension.
TABLE 4
THE TUBERCULOCIDAL ACTION OF STREPTOMYCIN
Units of streptomycin in Time of Dilution of tubercle bacilli planted
contact with 10 mg. of contact at (mg./cc.)
tubercle bacilli 370 C. 102 0O4 10o6
'o 2*- 2 4
8 hours 1 2 2 3
0 1 day | 2 | 2 1 3
Control 2 days | 2 2 | 3
4 days 2 2 3
I week | 2 1 2 1 3
0 1 2 1 2 1 3
8 hours | 2 2 1 3
10 I day | 2 2 | 3
2 days 2 2 3
4 days 2 | 2 3
1 week 2 | 3 4
0 1 2 1 2 1 3
8 hours 2 3 3 3
100 I day 1 2 2 3
2 days 2 3 4
4 days 2 | 3 3
I week| 2 3 4
0 2 2 __3
8 hours 2 2 3
1,000 1 day 1 2 2 3 3
2 days 2 [ 3 | 3
4 days | 2 3 4
I week 3 3 4
O 2 2 2
8 hours 2 2 3 2
10,000 I day | 2 | _3 |_3
2 days_ 2 3 | 3
4 days |_2 |_3 |_4
1 week | 3 | 4 | 4
* The numeral indicates the number of weeks
appeared.
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TABLE 5
THE TUBERCULOCIDAL ACTION OF STREPTOMYCIN IN THE PRESENCE OF BLOOD
Time of Amount of tubercle bacilli, in mii-
contact at grams, in contact with streptomycin
Units of streptomnycin 370 C. 0.01 | 0.000,01
0 3* 3
8hours 3 1 4
0 1day T 3 | 4
Control 2 days 3 4
4days 3 3 3
1week T 3 3
o T 3 3
8hours T 3 4
10 1day T 3 | 3
2 days 3 5
4days F 3 | 4
1 week 3 4
0 1 3 1 4
8hours 3 4
100 Iday | 3 | 4
2 days 3 4
4 days 3
I week 3 | 4
0 3 1 4
8 hours | 3 | 4
1,000 I day 3 4
2 days 3 1 4
4 days 3 4
1week 3 1 4
0 3 4
8 hours 3 1 4
10,000 1 day 3 | 4
2 days 3 | 5
4 days 3 | 5
1 week 3 0
*The numeral indicates the number of
appeared.
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The blood was treated with oxalic acid as is used for the diagnos-
tic cultures for tuberde bacilli before planting. This was not
necessary with the physiologic saline test.
The findings are clbvious, for the talbles show that even 10,000
units of streptomycin in saline do not destroy the tuberde bacilli
within one week; while in blood, 1,000 units of conitinuous contact
are without effect after one week, and 10,000 units for several days
have an apparent effect only on small numbers of bacilli (10-' mg.),
but not on 0.01 mg. per cc. during a week of contact.
Results of streptomycin treatment in vivo
The results recorded by previous authors leave no doubt but
that streptomycin appropriately applied will retard the development
of tubercullosis in the guinea-pig; but it must be recognized that this
alone, though of great academic significance to chemotherapy, does
not guarantee that prolionged application of streptomycin as a retard-
ant to human tulberculosis would be justified where the entire
pathological picture is much more complicated than is a single
primary animal inoculation with a highly virulent tuberde bacillus.
However, in order to gain an insight into this mechanism, only a
pie. 1
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few typical animal experiments will be briefed. The first, as
recorded in table 6, depicts the course of infection and treatment
of 4 guinea-pigs and 4 controls given an intravenous injection of 1
mg. of a fine suspension of virulent human tubrcle bacilli (cf. ref.
7). Treatment was started immediately with several daily subcu-
taneous injections of streptomycin (9,000 units a day) given each
treated guinea-pig. The purpose was to attack the bacilli with
streptomycin immediately upon their entrance into the body, to con-
TABLE 6
EFFECT OF STREPTOMYCIN ON GUINEA-PIGS GIVEN 1 MG. OF HIGHLY VIRULEN?
HUMAN TUBERCLE BACILLI (4008) INTRAVENOUSLY
Time after in-
fection when
animal was Organs Dilu of organs planted
killed or died Streptomycin treatment cultured 1:10 1:1,000
Lung | 3* [t 4 i
Killed, I day Control, Liver 14 -H [4
a
no treatment Spleen [3 H 6 6
Kidney 4 : 2 12 A
Lung 12 +++ 3 +
Died, 15 days Control, Liver | 3 H [ 3 +
no treatment I Spleen [3 - 1-H 3 +
_ Kidney 3 + [8 4
5 daily subcutaneous in- Lung | 3 I+t 3 +
Died, 28 days jections at 3-hour inter- Liver | 3 -i- 3 +
vals to total 9,000 units Spleen 3 +-- 3 +
a day Kidney 3 + | 6 +
Lung 3 -I--H 13 -H
Liver | 3 + TI 4. +
Died, 28 days " Spleen 1 3 -H-I- 3 +
_Kidney 3 + 5 4
Lung | 3 i--H- 3 -H
Died, 43 days CC *Liver 3 i--H- |3 +
Treatment discontinued Spleen T 3 -I-H- 3 +
_on 28th day Kidney 13 + |3 +
*The numeral indicates the number of weeks
appeared.
at 370 C. alt which growth
t The plus signs (from E to +-H) indicate the relative amount of growth noted.TUBERCLE BACILLUS AND ANTIBIOTIC ACTION 15
tinue treatment until the majority of the animals had died, and
then to discontinue treatment so as to note whether the streptomycin
had actually destroyed any of the bacilli. The duration of life and
weight of the spleen at the time .of death were as follows:
Duration of life and splenic weight
Infection controls: 1. Died 17 days, spleen
(Average duration of 2. Died 17 days, spleen
life, 18 days) 3. Died 18 days, spleen
4. Died 19 days, spleen
Streptomycin treated: 5. Died 21 days, spleen
(Average duration of 6. Died 28 days, spleen
life, 30 days) 7. Died 28 days, spleen
8. Died 43 days, spleen
2.2
2.0
3.2
2.2
5.6
1.9
3.4
3.5
gm.
gm.
gm.
gm.
gm.
gm.
gm.
gm.
Treatment was initiated with intravenous infection and con-
tinued until the 28th day. The treated animal dying on the 43rd
TABLE 7
ACCUMULATION OF STREPTOMYCIN IN THE ORGANS OF ANIMALS GIVEN
REPEATED INJECTIONS
Timeafter last injection
when animal was killed
and organs planted with Organs and culture results
Amount of streptomycin "Day" and tubercle l
injected subcutaneously bacilli Lung Liver SpleenI Kidney
Control
Guinea-pig or mouse +* + + +
8 daily injections of 20,- 2 days + I + | + I +
000 units each for a total 1 day + I + + +
of 160,000 units in 400- l
gm. guinea-pigs 1 hour + + + +
6 daily injections of
2,000 units, 5 of 4,000
units, 3 of 10,000 units,
and 4 of 20,000 units for 2 days + + + +
a total of 142,000 units
in a 20-gm. mouse
* "Day" is inhibited by one unit per cc. in nutrient broth; the + indicates
absence of retardation of growth and thus absence of any antibiotic effect in vitro.
The tissue does not interfere with the antibiotic test.YALE JOURNAL OF BIOLOGY AND MEDICINE
day showed definitely that progression followed cessation of treat-
ment, to atermination in less time than was required for the con'trols
to die after initial infection.
The results recorded in table 6 leave no doubt of the retarding
effect of streptomycin on tulberculosis in the guinea-pig, but it is
also evident that this effect lasts only so long as treatment continues.
There is no evidence that in the amounts used it is able to destroy
tubercle bacilli in vivo.
Accumulation of streptomwycin in the organs
In view of the possibility of the accumulation of streptomycin
in certain organs, which, if true, would serve to prolong its effect
beyond the period of treatment, the organic persistence was studied
in guinea-pigs and mice with the results recorded in table 7.
The findings recorded in table 7 do not lend support to the
assumption that there is an accumulation of streptomycn in the
organs of the guinea-pig or mouse after repeated suibcutaneous
injections.
Adsorption ofstreptomycin by tubercle bacilli and by the tubercle
In order to note whether or not there is a selective adsorption
of streptomycin in vitro or in vivo, an experiment was performed
with suspensions of tubercle bacilli (viable and nonviable) to which
streptomycin had been added. After a certain interval of time,
the bacilli and suspending fluid were assayed for streptomycin, with
the results recorded in talble 8.
The data recorded in table 8 present no evidence of a selective
adsorption of streptomycin by tubercle bacilli.
In order -to gain an insight into the adsorption of streptomycin
by tfhe tubercle and its contained tu'bercle bacilli, 100 mg. of viable
tufbercle bacilli were injected ¶sulbcutaneously into a inumber of
guinea-pigs 10 days prior to streptomycin treatment. The strepto-
mycin was given in three doses intravenously at hourly intervals for
a total of 100,000 units. The blood was obtained for streptomycin
examination by cardiac puncture one hour after the last intravenous
injection of streptomycin, at which time the animal was killed and
the tubercle and its contained pus were removed with aseptic pre-
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cautions. The blood and tuberde (ground) were assayed for strep-
tomycin, using adid-fast saprophyte "Day" as test organism.
TABLE 9
ANALYSIS OF THE TUBERCLE FOR STREPTOMYCJN ADSORPTION
| Units of streptomycin per cc.
Treatment Tissue 2 4 4I 8 | 16 32] 64 128
Control, Blood |O*l i + l+ l
no treatment Tubercle I + + l + +
100,000 units strep-
B l lo_ l
tomycin in 3 divided Blood lO 0 0 0 OO
doses intravenously, l
hourly Tubercle J + + + I + | __ + |+
* 0 indicates a complete retarding effect on growth of the acid-fast saprophyte
"Day"; + indicates complete absence of retardation.
The data recorded in table 9 do not indicate the presence, within
an hour of the last injection, of an appreciable amount of strepto-
mycin in the tubercle in guinea-pigs after the intravenous injection
of a total of 100,000 units in three divided hourly doses.
Taible 10 shows the inability of relatively large amounts of
streptomycin to destroy acid-fast organisms and tubercle bacilli in
vivo.
The results recorded in table 10 do not appear to justify the
conclusion that streptomycin is alble to destroy acid-fast saprophytes
or mammalian tubercle bacilli in vivo, even when used subcuta-
neously in daily amounts of a half million units per kilo.
Summary and conclusions
1. Streptomycin properly administered and in proper dosage is
capable of retarding the development or growth of human tubercle
bacilli, both in vitro (in good nutrient mediums as well as in poor
ones) and in vivo.
2. The concentration of streptomycin required to retard the
growth of tubercle bacilli in vitro in good nut-rient medium can
only be attained in vivo for a 'brief period by any route of adminis-
tration or amount of streptomycin that can 'be used even with the
present high assay unit preparations.
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3. There is no evidence availaible at present to indicate that
streptomycin enters the important organs in appreciable amount for
any significant time although it is present in the blood, or that it
accumulates in these organs.
4. There is no evidence at present that tubercle bacilli adsorb
or absoirb streptomycin or that it accumulates in .these bacilli in vitro
or in vivo.
5. To the best of our knowledge, streptomycin is a metabolite
of Actinomyces griseus and is not tulberculocidal in reasonable
amounts, but it produces its effects in vivo, and in vitro primarily,
asaretardant of the growth of tubercle bacilli when they are actively
developing or reproducing. It appears to be a tuberculo-toxic
metabolite of the Actinomyces griseus, aotive by retarding tutberculo-
anabolism. In the usual case of clinical tuberculosis in man, the
bacilli appear to reproduce and develop only at irregular periods
undeterminable by clinical means and over long periods of time,
and this markedly reduces the applicability of a retardant without
tuberculocidal action for use in human tuberculosis.
6. How much further the purity and dosage of streptomycin
can be increased to achieve ihigher concentrations for use in man
remains for future laboratory investigations to disclose. Academi-
cally, however, streptomycin is another encouraging milestone for
those who have had faith in a chemotherapy for tuiberculosis-the
sulfones as retardants for guinea-pig tuberculosis, and now the
antibiotic streptomycin as a metabolite retardant, interfering with
tuberculo-anabolism. This makes its application limited, if at all
possible, in human tuberculosis, but it may yet indicate the selective
tuberculocide through laboratory experiment.
REFERENCES
1 Anderson, D. G., and M. Jewell: Absorption, excretion and toxicity of strep-
tomycin in man. New England J. Med., 1945, 233, 485.
2 Baggenstoss, A. H., W. H. Feldman, and H. C. Hinshaw: The effect of
streptomycin on the histopathology of human tuberculosis. Scient. Proc.
Am. J. Path., 1946, 22, 641-42.
3 Carter, H. E., R. K. Clark, S. R. Dickman, Y. H. Loo, P. S. Skell, and W. A.
Strong: Isolation and purification of streptomycin. J. Biol. Chem.,
1945, 160, 337-42.
4 Cohn, M. L.: The antiseptic effect upon tubercle bacilli of certain recently
advocated compounds. J. Bact., 1934, 27, 517.TUBERCLE BACILLUS AND ANTIBIOTIC ACTION 21
5 Corper, H. J.: Lysozyme and tuberculosis. Am. Rev. Tuberc., 1932, 25,
59-66.
6 Corper, H. J., and C. Clark: Retardants to the growth of tubercle bacilli:
The effect of caramelization on growth. Am. Rev. Tuberc., 1946
(In press).
7 Corper, H. J., and M. L. Cohn: The use of diasone for the treatment of
tuberculosis. J. Am. Med. Asso., 1945, 127, 1043-49.
8 Corper, H. J., and Nao Uyei: The isolation of tubercle bacilli from con-
taminated tuberculous material. Am. Rev. Tuberc., 1927, 16, 299-322.
9 Corper, H. J., and N. Uyei: Oxalic acid as a reagent for isolating tubercle
bacilli and a study of the growth of acid fast nonpathogens on different
mediums with their reaction to chemical reagents. J. Lab. & Clin. Med.,
1930, 15, 348-72.
10 Donovich, R., D. Hamre, F. Kavanagh, and G. Rake: A broth dilution
method of assaying streptothricin and streptomycin. J. Bact., 1945, 50,
623-28.
11 Donovich, R., and G. Rake: Influence of certain substances on activity of
streptomycin. I. Modification in test mediums. Proc. Soc. Exper.
Biol. & Med., 1946, 61, 224-27.
12 Feldman, W. H., and H. C. Hinshaw: Effects of streptomycin on experi-
mental tuberculosis in guinea pigs. A preliminary report. Proc. Staff
Meet., Mayo Clin., 1944, 19, 593-99.
13 Forgacs, J., G. B. Kornegay, and T. F. Henley: Studies on streptomycin.
I. Assay in body fluids. J. Lab. & Clin. Med., 1946, 31, 514-22.
14 Frieden, E. H.: The nature and action of the antibiotics. Texas Rep.
Biol. & Med., 1945, 3, 569-646.
15 Heilman, Dorothy H.: Cytotoxicity of streptomycin and streptothricin.
Proc. Soc. Exper. Biol. & Med., 1945, 60, 365-67.
16 Herrell, Wallace E.: Penicillin and other Antibiotic Agents. W. B. Saun-
ders Co., 1945.
17 Hettig, R. A., and J. D. Adcock: Studies on the toxicity of streptomycin for
man. A preliminary report. Science, 1946, 103, 355-57.
18 Kornegay, G. B., J. Forgacs, and T. F. Henley: Studies on streptomycin.
II. Blood levels and urinary excretion in man and animals. J. Lab. &
Clin. Med., 1946, 31, 523-34.
19 Oxford, Albert E.: The chemistry of antibiotic substances other than peni-
cillin. Ann. Rev. Biochem., 1945, 14, 749-72.
20 Robinson, H. J., D. G. Smith, and 0. E. Graessle: Chemotherapeutic
properties of streptomycin. Proc. Soc. Exper. Biol. & Med., 1944, 57,
226-31.
21 Schatz, A., E. Bugie, and S. A. Waksman: Streptomycin, a substance exhibit-
ing antibiotic activity against gram positive and gram negative bacteria.
Proc. Soc. Exper. Biol. & Med., 1944, 55, 66-69.
22 Smith, Dorothy G.: A method for detection of streptothricin in the presence
of streptomycin. Proc. Soc. Exper. Biol. & Med., 1946, 61, 214-16.
23 Smith, Dorothy G., and H. J. Robinson: The influence of streptomycin and
streptothricin on the intestinal flora of mice. J. Bact., 1945, 50, 613-21.22 YALE JOURNAL OF BIOLOGY AND MEDICINE
24 Smith, M. I., and W. T. McClosky: The chemotherapeutic action of strep-
tomycin and promin in experimental tuberculosis. Public Health Reports,
1945, 60, 1129-38.
25 Stebbins, R. B., 0. E. Graessle, and H. J. Robinson: Studies on the absorp-
tion and excretion of streptomycin. Proc. Soc. Exper. Biol. & Med.,
1945, 60, 68-72.
26 Tice, Frederick, Henry C. Sweany, and Richard Davison: The sulfones in
clinical tuberculosis. Am. Rev. Tuberc., 1946, 53, 475-95.
27 Waksman, Selman A.: Microbial Antagonisnms and Antibiotic Substances.
Commonwealth Fund, New York, 1945.
28 Waksman, Selman A.: Standardization of streptomycin. Science, 1945, 102,
40-41.
29 Waksman, Selman A., and Albert Schatz: Isolation of antibiotic substances
from soil micro-organisms with special reference to streptothricin and
streptomycin. Proc. Staff Meet., Mayo Clin., 1944, 19, 537-48.
30 Wallace, G. I., I. Rhymer, 0. Gibson, and M. Shattuck: Studies on mode of
action of streptomycin. Proc. Soc. Exper. Biol. & Med., 1945, 60,
127-28.
31 Youmans, G. P., E. H. Williston, W. H. Feldman, and H. C. Hinshaw:
Increase in resistance of tubercle bacilli to streptomycin. A preliminary
report. Proc. Staff Meet., Mayo Clin., 1946, 21, 126-27.